1.75
price down icon3.31%   -0.06
after-market 시간 외 거래: 1.83 0.08 +4.57%
loading
전일 마감가:
$1.81
열려 있는:
$1.8
하루 거래량:
24,057
Relative Volume:
0.90
시가총액:
$9.62M
수익:
-
순이익/손실:
$-14.29M
주가수익비율:
-0.4386
EPS:
-3.99
순현금흐름:
$-12.27M
1주 성능:
+0.57%
1개월 성능:
+1.16%
6개월 성능:
-50.00%
1년 성능:
-62.79%
1일 변동 폭
Value
$1.75
$1.8699
1주일 범위
Value
$1.74
$2.00
52주 변동 폭
Value
$1.412
$5.01

Aprea Therapeutics Inc Stock (APRE) Company Profile

Name
명칭
Aprea Therapeutics Inc
Name
전화
215-948-4119
Name
주소
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Name
직원
8
Name
트위터
Name
다음 수익 날짜
2024-12-07
Name
최신 SEC 제출 서류
Name
APRE's Discussions on Twitter

APRE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APRE
Aprea Therapeutics Inc
1.75 9.62M 0 -14.29M -12.27M -3.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-12-28 다운그레이드 Robert W. Baird Outperform → Neutral
2020-12-16 개시 Berenberg Buy
2020-09-29 재개 JP Morgan Neutral
2020-06-22 개시 H.C. Wainwright Neutral
2020-04-21 개시 Robert W. Baird Outperform
2019-10-28 개시 JP Morgan Neutral
2019-10-28 개시 Morgan Stanley Equal-Weight
2019-10-28 개시 RBC Capital Mkts Outperform
모두보기

Aprea Therapeutics Inc 주식(APRE)의 최신 뉴스

pulisher
Jun 05, 2025

Aprea Therapeutics Teams Up with MD Anderson for Preclinical HNSCC Research - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Aprea Therapeutics expands cancer drug patent portfolio - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Takes $43,000 Position in Aprea Therapeutics, Inc. (NASDAQ:APRE) - Defense World

Jun 04, 2025
pulisher
May 22, 2025

Acute Myeloid Leukemia Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - openPR.com

May 22, 2025
pulisher
May 22, 2025

Ovarian Cancer Drugs Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - openPR.com

May 22, 2025
pulisher
May 19, 2025

Q2 Earnings Estimate for APRE Issued By Wedbush - Defense World

May 19, 2025
pulisher
May 18, 2025

Eton Pharmaceuticals (NASDAQ:ETON) Earns “Buy” Rating from B. Riley - Defense World

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Sells 752 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Purchases 993 Shares of CTO Realty Growth, Inc. (NYSE:CTO) - Defense World

May 18, 2025
pulisher
May 18, 2025

InMode Ltd. (NASDAQ:INMD) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 18, 2025
pulisher
May 18, 2025

What is Wedbush’s Estimate for ORKA FY2029 Earnings? - Defense World

May 18, 2025
pulisher
May 18, 2025

Wedbush Forecasts Lower Earnings for Aprea Therapeutics - Defense World

May 18, 2025
pulisher
May 16, 2025

Petro-Victory Energy Corp. Announces Short Term Loan - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Stocks Close Higher On Optimism Over US Trade Negotiations - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Ontario Lottery And Gaming CorporationMidDay Lottery Winning NumbersMay 16, 2025 - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Becton, Dickinson And Company Stock: Analyst Estimates & Ratings - Barchart.com

May 16, 2025
pulisher
May 16, 2025

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Strathcona Resources Ltd. Reports First Quarter 2025 Financial and Operating Results, Announces Quarterly Dividend and Investment in MEG Energy Corp. - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Aprea Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 16, 2025
pulisher
May 15, 2025

NoticeGO-TO DEVELOPMENTS HOLDINGS INC., GO-TO SPADINA ADELAIDE SQUARE INC., FURTADO HOLDINGS INC., and OSCAR FURTADO, File No. 2022-8 - Barchart.com

May 15, 2025
pulisher
May 15, 2025

RBC Global Asset Management Inc. Announces RBC ETF Cash Distributions For May 2025 - Barchart.com

May 15, 2025
pulisher
May 14, 2025

Strathcona Resources Ltd. Announces Sale of Montney Business for $2.84 Billion and Acquisition of Hardisty Rail Terminal - Barchart.com

May 14, 2025
pulisher
May 14, 2025

BIG ROCK BREWERY INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS - Barchart.com

May 14, 2025
pulisher
May 14, 2025

Psychemedics Named “Most Innovative Drug Testing Company Of The Year” - Barchart.com

May 14, 2025
pulisher
May 14, 2025

This Under-The-Radar Cancer Biotech Reports 21% Tumor Shrinkage: Analysts See 600%+ Upside - Barchart.com

May 14, 2025
pulisher
May 14, 2025

GFL Environmental Inc. Announces Results From Annual General Meeting Of Shareholders - Barchart.com

May 14, 2025
pulisher
May 14, 2025

Aprea (APRE) Reports Q1 Revenue Drop Amid Clinical Progress | AP - GuruFocus

May 14, 2025
pulisher
May 14, 2025

APRE Reports Decrease in Cash Reserves by End of Q1 2025 | APRE Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics Reports Promising Q1 2025 Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics reports Q1 EPS (66c) vs. (67c) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update - GlobeNewswire Inc.

May 14, 2025
pulisher
May 13, 2025

Stocks In Play: Knight Therapeutics Inc - Barchart.com

May 13, 2025
pulisher
May 12, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) To Report Q1 2025 Results On May 15 - Barchart.com

May 12, 2025
pulisher
May 09, 2025

Aprea Therapeutics Inc expected to post a loss of 86 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 09, 2025

Stocks In Play: Galiano Gold Inc. - Barchart.com

May 09, 2025
pulisher
May 09, 2025

Stocks In Play: Illumin Holdings Inc. - Barchart.com

May 09, 2025
pulisher
May 09, 2025

PBYI Stock Rises As Q1 Earnings And Sales Beat Estimates - Barchart.com

May 09, 2025
pulisher
May 09, 2025

Japanese Tech Company Panasonic Cuts 4% Of Its Global Workforce As Profits Falter - Barchart.com

May 09, 2025
pulisher
May 08, 2025

LifeSpeak Inc. Announces First Quarter 2025 Results - Barchart.com

May 08, 2025
pulisher
May 08, 2025

Stocks In Play: Knight Therapeutics Inc. - Barchart.com

May 08, 2025
pulisher
May 07, 2025

PIZZA PIZZA ROYALTY CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS - Barchart.com

May 07, 2025
pulisher
May 06, 2025

Adicet Bio Advances Two Breakthrough Therapies: Key Clinical Data Coming in 2025 for Lupus and Cancer Programs - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Business Wire

May 06, 2025
pulisher
May 05, 2025

IGM FINANCIAL INC. ANNOUNCES APRIL 2025 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS - Barchart.com

May 05, 2025
pulisher
May 04, 2025

Larimar Therapeutics Reports Q1 2025 Results and Advances Nomlabofusp Development - MyChesCo

May 04, 2025
pulisher
May 02, 2025

LPL Financial LLC Makes New $53,000 Investment in Aprea Therapeutics, Inc. (NASDAQ:APRE) - Defense World

May 02, 2025
pulisher
May 01, 2025

3 Consumer Discretionary Stocks to Buy in a Divided Economy - The Globe and Mail

May 01, 2025
pulisher
Apr 30, 2025

Carnival Corporation Earnings Preview: What To Expect - Barchart.com

Apr 30, 2025

Aprea Therapeutics Inc (APRE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Aprea Therapeutics Inc 주식 (APRE) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Duey Marc
Director
Oct 18 '24
Sale
4.58
6,462
29,583
233,651
Gilad Oren
President/CEO
Oct 23 '24
Buy
3.92
500
1,958
333,395
Duey Marc
Director
Oct 16 '24
Buy
4.39
30,000
131,700
240,113
Gilad Oren
President/CEO
Oct 15 '24
Buy
2.90
250
725
332,895
Duey Marc
Director
Oct 14 '24
Buy
2.58
190
490
210,113
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Oct 11 '24
Buy
2.46
50
123
19,368
Seizinger Bernd R.
Director
Oct 11 '24
Buy
2.68
10,000
26,800
44,730
Gilad Oren
President/CEO
Oct 14 '24
Buy
2.59
1,000
2,590
332,645
Gilad Oren
President/CEO
Oct 10 '24
Buy
2.54
150
381
331,645
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Oct 10 '24
Buy
2.61
450
1,174
19,318
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):